07.26.11
A pilot clinical study published in Nutrition Journal concluded that a functional beverage from Sozo Global reduces inflammatory markers in vivo. The Sozo beverage contains a high ORAC, polyphenol-rich, proprietary formula of fruit and vegetable extracts featuring FutureCeuticals' patented CoffeeBerry brand coffee fruit extract.
The double-blind, placebo-controlled study compared the effects of a single dose of the Sozo beverage and a placebo on serum anti-inflammatory and antioxidant markers in the blood of 31 healthy human subjects randomized into the two groups.
At one hour after treatment, subjects in the Sozo group showed an average 40% reduction in blood levels of 8-iso-PGF-alpha (isoprostanes), a vasoconstrictor implicated in many inflammatory conditions including obesity, diabetes, arthritis and cardiovascular conditions. Reduction of isoprostanes levels remained evident for three hours following dosing. Administration of Sozo also yielded a 39% reduction in AOPP (advanced oxidation protein products), higher levels of which have been correlated with certain cardiovascular conditions.
The study authors conclude the results justify further clinical investigations into the beneficial effects of the Sozo beverage on human health. For further information: www.sozolife.com; www.futureceuticals.com
The double-blind, placebo-controlled study compared the effects of a single dose of the Sozo beverage and a placebo on serum anti-inflammatory and antioxidant markers in the blood of 31 healthy human subjects randomized into the two groups.
At one hour after treatment, subjects in the Sozo group showed an average 40% reduction in blood levels of 8-iso-PGF-alpha (isoprostanes), a vasoconstrictor implicated in many inflammatory conditions including obesity, diabetes, arthritis and cardiovascular conditions. Reduction of isoprostanes levels remained evident for three hours following dosing. Administration of Sozo also yielded a 39% reduction in AOPP (advanced oxidation protein products), higher levels of which have been correlated with certain cardiovascular conditions.
The study authors conclude the results justify further clinical investigations into the beneficial effects of the Sozo beverage on human health. For further information: www.sozolife.com; www.futureceuticals.com